![Study will evaluate firm’s retinal pigment cell therapy in Stargardt disease.[krishnacreations - Fotolia.com]](https://www.genengnews.com/wp-content/uploads/2018/08/Sept22_2011_22415259_ColorfulEyeball_StemCellTherapyBlindness6329668463-2-218x150.jpg "Using AI to Assess Eye Scans, Scientists Find “Retinal Age Gap” Predicts Mortality Risk")
Based in San Diego, Locanabio is built on the concept that gene therapy can deliver RNA-directed proteins to prevent or treat disease by targeting and modifying dysfunctional RNA . . .
Shooting the Messenger: Locanabio Writes a New Script for RNA Diseases
The San Diego start-up is creating a new class of gene therapies by targeting dysfunctional RNA
Source: David Bushnell, Ken Westover and Roger Kornberg, Stanford University
